Royal Bank of Canada
ENZ

Royal Bank of Canada’s Enzo Biochem, Inc. ENZ Stock Holding History

Royal Bank of Canada’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,000
Closed – – 7493
2025
Q1 		$0 Hold
1,000
– – ﹤0.01% 7363
2024
Q4 		$1K Hold
1,000
– – ﹤0.01% 6838
2024
Q3 		$1K Sell
1,000
-81
-7% -$91 ﹤0.01% 6760
2024
Q2 		$1K Hold
1,081
– – ﹤0.01% 6940
2024
Q1 		$1K Sell
1,081
-232
-18% -$306 ﹤0.01% 6901
2023
Q4 		$1K Buy
1,313
+228
+21% +$302 ﹤0.01% 7009
2023
Q3 		$1K Sell
1,085
-97
-8% -$146 ﹤0.01% 6969
2023
Q2 		$2K Buy
1,182
+182
+18% +$421 ﹤0.01% 6920
2023
Q1 		$2K Hold
1,000
– – ﹤0.01% 6817
2022
Q4 		$1K Buy
1,000
+500
+100% +$974 ﹤0.01% 7105
2022
Q3 		$1K Hold
500
– – ﹤0.01% 7309
2022
Q2 		$1K Hold
500
– – ﹤0.01% 7237
2022
Q1 		$1K Hold
500
– – ﹤0.01% 7634
2021
Q4 		$2K Sell
500
-900
-64% -$3.07K ﹤0.01% 7435
2021
Q3 		$5K Sell
1,400
-3,609
-72% -$12K ﹤0.01% 7154
2021
Q2 		$16K Buy
5,009
+1,295
+35% +$4.07K ﹤0.01% 6686
2021
Q1 		$13K Sell
3,714
-939
-20% -$2.92K ﹤0.01% 6692
2020
Q4 		$11K Buy
4,653
+4,141
+809% +$9.02K ﹤0.01% 6343
2020
Q3 		$1K Buy
512
+12
+2% +$29 ﹤0.01% 6499
2020
Q2 		$1K Sell
500
-634
-56% -$1.63K ﹤0.01% 6501
2020
Q1 		$3K Sell
1,134
-3,036
-73% -$7.46K ﹤0.01% 6226
2019
Q4 		$11K Buy
4,170
+2,937
+238% +$8.77K ﹤0.01% 6117
2019
Q3 		$5K Sell
1,233
-1,401
-53% -$4.96K ﹤0.01% 6056
2019
Q2 		$9K Buy
2,634
+1,881
+250% +$6.63K ﹤0.01% 6069
2019
Q1 		$2K Sell
753
-277
-27% -$907 ﹤0.01% 6559
2018
Q4 		$2K Sell
1,030
-258
-20% -$845 ﹤0.01% 6481
2018
Q3 		$5K Buy
1,288
+1,041
+421% +$4.73K ﹤0.01% 6289
2018
Q2 		$1K Buy
247
+162
+191% +$987 ﹤0.01% 6406
2018
Q1 		$0 Sell
85
-5
-6% -$35 ﹤0.01% 6876
2017
Q4 		$1K Sell
90
-3,214
-97% -$30.7K ﹤0.01% 6436
2017
Q3 		$35K Buy
+3,304
New +$36.7K ﹤0.01% 5630
2017
Q2 		– Sell
-1,011
Closed -$8K – 6815
2017
Q1 		$8K Sell
1,011
-1,655
-62% -$11.7K ﹤0.01% 6071
2016
Q4 		$19K Sell
2,666
-334
-11% -$2.13K ﹤0.01% 5804
2016
Q3 		$15K Buy
+3,000
New +$17.9K ﹤0.01% 5653
2016
Q2 		– Sell
-10
Closed – – 6557
2016
Q1 		$0 Buy
+10
New +$45 ﹤0.01% 6705
2015
Q4 		– Sell
-3
Closed – – 6849
2015
Q3 		$0 Hold
3
– – ﹤0.01% 6815
2015
Q2 		$0 Buy
+3
New +$8 ﹤0.01% 6753
2013
Q3 		– Sell
-300
Closed -$1K – 6294
2013
Q2 		$1K Buy
+300
New +$662 ﹤0.01% 5739

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Royal Bank of Canada's ENZ Position: Q2 2025 in Review

Royal Bank of Canada sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 1,000 shares.

Royal Bank of Canada first reported a position in ENZ in Q2 2013 and held it in 38 quarters. The position peaked at $35K in Q3 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Royal Bank of Canada reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 1,000 Enzo Biochem, Inc. shares in Q2 2025.
  • Royal Bank of Canada first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 38 quarters.
  • Royal Bank of Canada's Enzo Biochem, Inc. position peaked at $35K in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Royal Bank of Canada's 13F filing for Q2 2025, filed 14 Aug 2025.